Who
Michael J. Harrington
Director
Company insider
Files Form 4 as: Director, Elanco Animal Health; Director, Inotiv; Senior VP and General Counsel, Eli Lilly and.
In numbers
- Trades disclosed
- 70
- Buys
- 8
- Sells
- 2
- Bought
- $710K
- Sold
- $3.7M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 25 Jan 2013
- Last trade
- 12 Aug 2026
- Last filed
- 13 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 13 Aug 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $109K5,000 at $21.82 | filing |
| 12 Aug 2026filed 13 Aug 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $109K5,000 at $21.82 | filing |
| 19 Jul 2026filed 20 Jul 2026 | Inotiv | SEC FORM 4 Code J | —76,892 at $0.00 | filing |
| 19 Jul 2026filed 20 Jul 2026 | Inotiv | SEC FORM 4 Code J | —76,892 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 28 Nov 2025filed 2 Dec 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —10,314 at $0.00 | filing |
| 14 Mar 2025filed 18 Mar 2025 | Inotiv | SEC FORM 4 Code A | —39,392 at $0.00 | filing |
| 6 Dec 2024filed 10 Dec 2024 | Inotiv | SEC FORM 4 Bought | $40K10,000 at $3.98 | filing |
| 29 Nov 2024filed 3 Dec 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —18,169 at $0.00 | filing |
| 22 Aug 2024filed 26 Aug 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $52K3,500 at $14.85 | filing |
| 10 Aug 2024filed 14 Aug 2024 | Inotiv | SEC FORM 4 Code A | —27,500 at $0.00 | filing |
| 8 Mar 2024filed 12 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $50K3,100 at $16.29 | filing |
| 30 Nov 2023filed 4 Dec 2023 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —20,374 at $0.00 | filing |
| 30 Nov 2022filed 2 Dec 2022 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —18,649 at $0.00 | filing |
| 30 Nov 2021filed 2 Dec 2021 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $73K2,500 at $29.25 | filing |
| 30 Nov 2021filed 2 Dec 2021 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —7,307 at $0.00 | filing |
| 11 Aug 2021filed 13 Aug 2021 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Bought | $87K3,000 at $28.99 | filing |
News
No headline names them, or the companies they trade most, lately.